Validigm Biotechnology Inc Seattle, WA - 98104

Validigm Biotechnology Inc is categorized under High-Energy Particle Physics Equipment in Seattle, WA and active since 2012.

Validigm Biotechnology Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a High-Energy Particle Physics Equipment business, which does work in the BOTH market, and is classified as a High-Energy Particle Physics Equipment, under code number 335999 by the NAICS.

If you are seeking more information, feel free to contact Donna Hines at the company’s single location by writing to 821 2nd Avenue # 800, Seattle, Washington WA 98104 or by phoning (415) 205-3377. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Validigm Biotechnology Inc
Contact Person: Donna Hines
Address: 821 2nd Avenue # 800, Seattle, Washington 98104
Phone Number: (415) 205-3377
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: High-Energy Particle Physics Equipment
SIC Code: 3699
NAICS Code: 335999
Share This Business:

Validigm Biotechnology Inc was started in 2012 to provide professional High-Energy Particle Physics Equipment under the SIC code 3699 and NAICS code 335999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Donna Hines for inquiries that concern Validigm Biotechnology Inc by calling the company number (415) 205-3377, as your correspondence is most welcome. Additionally, the physical location of the single location of Validigm Biotechnology Inc can be found at the coordinates 47.604263,-122.334552 as well as the street address 821 2nd Avenue # 800 in Seattle, Washington 98104.

For its online presence, you may visit Validigm Biotechnology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.